{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:08:57Z","timestamp":1777860537302,"version":"3.51.4"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Variants in\n                      <jats:italic>RELA<\/jats:italic>\n                      (which encodes the p65 subunit of NF-\u03baB) can cause a monogenic autoinflammatory disease with clinical manifestations that range from mucocutaneous lesions (Beh\u00e7et\u2019s disease-like) to systemic inflammation. However, the diversity of the phenotype and its penetrance are uncertain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      Patient 1 (p.Asp465Thrfs14) presented with classic Beh\u00e7et\u2019s disease-like symptoms of oral and genital ulcers, fever, and elevated inflammatory markers. Colchicine (0.25 mg once daily) with low-dose glucocorticoids led to remission. Exploratory\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays using murine fibroblasts indicated increased TNF-\u03b1\u2013induced apoptosis associated with the\n                      <jats:italic>RELA<\/jats:italic>\n                      variant. Patient 2 (p.Glu495Serfs6) had no mucosal lesions but experienced recurrent high fever, hyperferritinemia, uveitis\/scleritis, and progressive bilateral sensorineural hearing loss. Because IL-1 blockers were not available, we administered adalimumab as a steroid-sparing treatment. Defervescence was achieved within 6 months of adalimumab therapy, with stabilization of inflammatory markers and hearing thresholds during the entire 9-month follow-up. PBMCs from Patient 2 and the carrier mother that were stimulated by LPS had decreased induction of two genes targeted by NF-\u03baB (\n                      <jats:italic>BCL2A1<\/jats:italic>\n                      ,\n                      <jats:italic>TRAF1<\/jats:italic>\n                      ), and the proband (but not the mother) had markedly increased IL-6 secretion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      C-terminal truncations in the transcriptional activation domain of\n                      <jats:italic>RELA<\/jats:italic>\n                      lead to haploinsufficiency and an inflammatory phenotype that depends on the cell type and stimulus.\n                      <jats:italic>RELA<\/jats:italic>\n                      screening should be considered in the evaluation of children with unexplained autoinflammatory presentation, even in the absence of mucosal ulceration.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1756745","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:56:38Z","timestamp":1771397798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Diverse pediatric phenotypes of RELA frameshift variants: comparison of two cases"],"prefix":"10.3389","volume":"17","author":[{"given":"Ling","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e12973","DOI":"10.1111\/sji.12973","article-title":"Beh\u00e7et disease (BD) and BD-like clinical phenotypes: NF-\u03baB pathway in mucosal ulcerating diseases","volume":"92","author":"Perazzio","year":"2020","journal-title":"Scandinavian J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/children8020075","article-title":"Primary immunodeficiency disease mimicking pediatric bechet\u2019s disease","volume":"8","author":"Shiraki","year":"2021","journal-title":"Children (Basel Switzerland)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160724","article-title":"Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration","volume":"214","author":"Badran","year":"2017","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/art.41531","article-title":"A novel RELA truncating mutation in a familial beh\u00e7et\u2019s disease-like mucocutaneous ulcerative condition","volume":"73","author":"Adeeb","year":"2021","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac227","article-title":"Case report and review of the literature: immune dysregulation in a large familial cohort due to a novel pathogenic RELA variant","volume":"62","author":"Lecerf","year":"2022","journal-title":"Rheumatol (Oxford England)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jaci.2017.11.036","article-title":"RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias","volume":"141","author":"Comrie","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212276","article-title":"Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity","volume":"220","author":"Moriya","year":"2023","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127085","article-title":"Case report: Novel variants in RELA associated with familial Behcet\u2019s-like disease","volume":"14","author":"An","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3888","article-title":"Random monoallelic expression of autosomal genes: stochastic transcription and allele-level regulation","volume":"16","author":"Reinius","year":"2015","journal-title":"Nat Rev Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08346-4","article-title":"Monoallelic expression can govern penetrance of inborn errors of immunity","volume":"637","author":"Stewart","year":"2025","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1756745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:56:40Z","timestamp":1771397800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1756745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":11,"alternative-id":["10.3389\/fimmu.2026.1756745"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1756745","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1756745"}}